Repro Med Systems (KRMD) Tops Q1 EPS by 3c, provides guidance

Repro Med Systems (NASDAQ: KRMD) reported Q1 EPS of $0.00, $0.03 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $9.6 million versus the consensus estimate of $8.79 million.

GUIDANCE:

Repro Med Systems sees FY2025 revenue of $38.5-39.5 million, versus the consensus of $38.429 million.

For earnings history and earnings-related data on Repro Med Systems (KRMD) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August